William E Boden
Affiliation: State University of New York at Buffalo
- Optimal medical therapy with or without PCI for stable coronary diseaseWilliam E Boden
Western New York Veterans Affairs Healthcare Network and Buffalo General Hospital SUNY, Buffalo, NY 14203, USA
N Engl J Med 356:1503-16. 2007....
- Interpreting the results of the COURAGE trial: a non-interventionalist perspectiveWilliam E Boden
Department of Medicine and Preventive Medicine, University at Buffalo School of Medicine, and Buffalo General Hospital, Buffalo, NY, USA
Rev Cardiovasc Med 10:S34-44. 2009..The important quality-of-life findings permit physicians to engage in an evidence-based discussion with patients about the expected clinical and health status benefits of initial versus deferred PCI when added to OMT...
- The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialWilliam E Boden
VA Connecticut Healthcare System, West Haven, Connecticut, USA
Am J Cardiol 99:208-12. 2007....
- Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management optionsWilliam E Boden
School of Medicine and Biomedical Sciences, State University of New York, and Kaleida Health System, Buffalo, New York, USA
J Am Coll Cardiol 50:917-29. 2007..Results from ongoing clinical trials will provide guidance regarding the utility of this strategy...
- Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosisWilliam E Boden
Department of Cardiology, Buffalo General and Millard Fillmore Hospitals and Division of Cardiovascular Medicine, Schools of Medicine and Public Health, State University of New York at Buffalo, NY, USA
Crit Pathw Cardiol 9:116-25. 2010..Patients without prior cardiovascular intervention had a lower intensity of risk factor modification at baseline and appear to represent an at-risk, undertreated population...
- Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspectiveWilliam E Boden
Buffalo General Hospital and SUNY, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA
Cardiovasc Drugs Ther 24:207-16. 2010....
- Interpreting the COURAGE trial. It takes COURAGE to alter our belief systemWilliam E Boden
University at Buffalo Schools of Medicine and Public Health, Buffalo General and Millard Fillmore Hospitals, Buffalo, NY 14203, USA
Cleve Clin J Med 74:623-5, 629-33. 2007
- ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapyWilliam E Boden
Buffalo General Hospital, Buffalo, NY, USA
Am J Emerg Med 26:212-20. 2008..Recent trials support the development of an early and aggressive approach to more complete platelet inhibition using clopidogrel, in combination with ASA, for patients with STEMI...
- Management of chronic coronary disease: is the pendulum returning to equipoise?William E Boden
University at Buffalo Schools of Medicine and Public Health, 100 High Street, Buffalo, NY 14203, USA
Am J Cardiol 101:69D-74D. 2008..Thus, the treatment pendulum may be swinging back to the understanding that "best practice" today requires the judicious use of interventional and medical therapies in the appropriate patient population...
- Reperfusion strategies in acute ST-segment elevation myocardial infarctionWilliam E Boden
Division of Cardiovascular Medicine, University at Buffalo Schools of Medicine and Public Health, Buffalo, NY 14203, USA
Curr Opin Cardiol 23:613-9. 2008....
- Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)William E Boden
VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, NY, USA
Am J Cardiol 104:1-4. 2009....
- Acute coronary syndromes: selective vs early invasive strategiesWilliam E Boden
Division of Cardiovascular Medicine, University at Buffalo Schools of Medicine and Public Health, Division of Cardiology, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA
Clin Cardiol 32:621-6. 2009..To facilitate this goal, we examined key differences between the 2002 and 2007 guidelines and explored data underlying changed recommendations for periprocedural pharmacotherapy...
- Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424William E Boden
VA Connecticut Healthcare System, West Haven, CT, USA
Am Heart J 151:1173-9. 2006....
- Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitalsCraig I Coleman
Division of Cardiology, Hartford Hospital, Hartford, CT 06102 5037, USA
Clin Ther 28:1054-62. 2006..This approach, however, has not been systematically evaluated...
- Introduction to "Optimizing management of non-ST-segment elevation acute coronary syndromes". Harmonizing advances in mechanical and pharmacologic interventionWilliam E Boden
Division of Cardiology, Hartford Hospital, Hartford, Connecticut, USA
J Am Coll Cardiol 41:1S-6S. 2003
- Medical therapy in acute coronary syndromes: which medicines and at what doses?Dmitriy Kireyev
Division of Cardiology, Buffalo General Hospital, Buffalo, NY 14203, USA
Curr Cardiol Rep 11:267-75. 2009..This is an exciting time to be involved in the field of cardiovascular medicine, as we continue to see profound improvement from medical therapy in the morbidity and mortality associated with ACS...
- The evolving role of medical therapy for chronic stable anginaFreidy Eid
Division of Cardiology, Buffalo General Hospital, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203, USA
Curr Cardiol Rep 10:263-71. 2008....
- Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney diseaseSteven P Sedlis
New York University School of Medicine, New York, NY, USA
Am J Cardiol 104:1647-53. 2009..Although PCI did not reduce the risk of death or myocardial infarction when added to OMT for patients with CKD, it also was not associated with worse outcomes in this high-risk group...
- Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromesMatthew T Roe
Department of Medicine, Division of Cardiovascular Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Eur Heart J 29:2480-8. 2008..We sought to determine the prevalence and prognostic significance of low HDL cholesterol levels in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
- Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh
Mount Sinai School of Medicine, New York, New York 10029, USA
J Am Coll Cardiol 61:1607-15. 2013....
- The role of revascularization versus medical therapy in patients with type 2 diabetes mellitus and coronary artery diseaseBrian J Page
Division of Cardiology, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA
Curr Diab Rep 10:10-5. 2010..Ongoing trials of diabetic patients with CAD randomized to PCI or CABG will help further elucidate the role of PCI with DES as a potential revascularization option for this patient population...
- Signs and symptoms of suspected myocardial ischemia in women: results from the What is the Optimal Method for Ischemia Evaluation in WomeN? TrialJennifer H Mieres
North Shore University Hospital, Manhasset, New York, USA
J Womens Health (Larchmt) 20:1261-8. 2011....
- Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia managementWilliam E Boden
Division of Cardiology, Hartford Hospital, Hartford, CT 06102 5037, USA
Curr Opin Cardiol 18:278-85. 2003....
- Emerging medical treatment for angina pectorisStanley F Fernandez
State University of New York at Buffalo, Division of Cardiovascular Medicine, 100 High St, Buffalo, 14203, NY, USA
Expert Opin Emerg Drugs 15:283-98. 2010..Despite improved mortality and morbidity in the treatment of coronary artery disease, a significant proportion of patients will continue to experience recurrent angina pectoris...
- Contemporary approach to the diagnosis and management of non-ST-segment elevation acute coronary syndromesWilliam E Boden
Division of Cardiology, Department of Medicine, Buffalo General Hospital and Kaleida Health, State University of New York SUNY at Buffalo School of Medicine and Biomedical Science, Buffalo, NY 14203, USA
Prog Cardiovasc Dis 50:311-51. 2008....
- Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trialsStanley F Fernandez
Division of Cardiovascular Medicine, University at Buffalo and Buffalo General Hospital, University at Buffalo School of Medicine, State University of New York at Buffalo, Buffalo, NY, USA
Curr Atheroscler Rep 12:423-31. 2010..For diabetic patients who have extensive coronary artery disease, early revascularization with CABG may be reasonable...
- Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratoryRichard A Kerensky
Malcom Randall Veterans Affairs Medical Center and the University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida 32610 0277, USA
J Am Coll Cardiol 39:1456-63. 2002..We sought to determine the underlying coronary anatomy and characterize the culprit lesion after non-Q-wave myocardial infarction (NQWMI)...
- Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndromeWilliam E Boden
Samuel S Stratton VA Medical Center, Albany Medical College, New York, USA
Am J Cardiol 111:439-44. 2013....
- DTCA for PTCA--crossing the line in consumer health education?William E Boden
Division of Cardiovascular Medicine, University at Buffalo Schools of Medicine and Public Health, and Buffalo General Hospital, Buffalo, NY, USA
N Engl J Med 358:2197-200. 2008
- Clinical utility of aVR-The neglected electrocardiographic leadDmitriy Kireyev
State University of New York at Buffalo, USA
Ann Noninvasive Electrocardiol 15:175-80. 2010..Several studies suggest that electrocardiographers tend to neglect lead aVR during the reading of electrocardiograms (ECGs). Our objective was to provide a systematic review of the most important diagnostic and prognostic uses of lead aVR...
- Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?Kathleen A Cheng-Torres
Division of Cardiology, Department of Medicine, Albany Medical Center, NY 10021, USA
Future Cardiol 12:35-44. 2016....
- A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectorisSabu Thomas
Division of Cardiology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA
Can J Cardiol 29:472-82. 2013....
- 50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directionsHiroko Beck
University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA
Am J Cardiol 106:810-8. 2010..In conclusion, Greatbatch's historic achievement 50 years ago reminds us that technologic progress is timeless, as efforts to enhance clinical outcomes and the quality of life continue unimpeded into the 21st century...
- Low levels of high-density lipoprotein cholesterol: an independent risk factor for late adverse cardiovascular events in renal transplant recipientsKulpreet Barn
Department of Medicine, State University of New York, University at Buffalo, Buffalo General Hospital, Kaleida Health, Buffalo, NY 14203, USA
Transpl Int 23:574-9. 2010..In the low HDL group, the odds ratio for experiencing a MACE was 1.92. Therefore, HDL cholesterol may provide an important new therapeutic target to prevent vascular morbidity and mortality following renal transplantation...
- The role of pharmacotherapy and catheter-based intervention in the management of patients with non-ST-segment elevation acute coronary syndromesWilliam E Boden
Hartford Hospital, 80 Seymour Street, CT 06102, USA
Curr Cardiol Rep 4:260-71. 2002....
- Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitalsMatthew T Roe
Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 156:185-92. 2008....
- Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysisMichelle O'Donoghue
TIMI Study Group, Brigham and Women s Hospital, 350 Longwood Ave, First Floor, Boston, MA 02115, USA
JAMA 300:71-80. 2008..Although an invasive strategy is frequently used in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS), data from some trials suggest that this strategy may not benefit women...
- Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trialMaria Elenita Favarato
Heart Institute InCor, University of Sao Paulo School of Medicine, Sao Paulo, SP, Brazil
Int J Cardiol 116:364-70. 2007..We evaluated the impact of Coronary Artery Bypass Graft Surgery (CABG), Percutaneous Coronary Intervention (PCI) or Medical Therapy (MT) on self-perceived quality of life among patients with stable Coronary Artery Disease (CAD)...
- Effect of PCI on quality of life in patients with stable coronary diseaseWilliam S Weintraub
Christiana Care Health System, Newark, DE 19718, USA
N Engl J Med 359:677-87. 2008..It has not been clearly established whether percutaneous coronary intervention (PCI) can provide an incremental benefit in quality of life over that provided by optimal medical therapy among patients with chronic coronary artery disease...
- Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement InitiativeDeepak L Bhatt
Cleveland Clinic Foundation, Department of Cardiovascular Medicine Desk F25, Cleveland, Ohio 44195, USA
JAMA 292:2096-104. 2004....
- Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert ProgramChristopher P Cannon
Cardiovascular Division, Brigham and Women s Hospital, Boston, MA, USA
Am Heart J 143:777-89. 2002..However, no systematic review exists regarding the value of critical pathways in this setting...
- Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta
Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada L6K 1B8
JAMA 293:2908-17. 2005....
- Surgery, angioplasty, or medical therapy for symptomatic multivessel coronary artery disease: is there an indisputable "winning strategy" from evidence-based clinical trials?William E Boden
J Am Coll Cardiol 43:1752-4. 2004
- Practical approach to incorporating new studies and guidelines for antiplatelet therapy in the management of patients with non-ST-segment elevation acute coronary syndromeWilliam E Boden
Am J Cardiol 93:69-72. 2004
- Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic interventionJames L Januzzi
Cardiology Division, Massachusetts General Hospital, Boston, Mass, USA
Am Heart J 146:764-74. 2003..In addition, we will consider appropriate methods/venues for use of GP IIb/IIIa receptor antagonism, including its role in an "early invasive" catheterization strategy...
- Is it time to reassess the optimal timing of coronary artery bypass graft surgery following acute myocardial infarction?William E Boden
Am J Cardiol 90:35-8. 2002
- "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition eraWilliam E Boden
Division of Cardiology and the Henry Low Heart Center, Hartford Hospital, Hartford, Connecticut 06102, USA
J Am Coll Cardiol 41:113S-122S. 2003..Optimal management should incorporate both strategies...
- Cardioprotective effects of an early invasive strategy for non-ST-segment elevation acute coronary syndromes: are we all becoming "interventional" cardiologists?Ravi K Yarlagadda
J Am Coll Cardiol 40:1915-8. 2002
- Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) TrialFrederick F Samaha
Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Am J Cardiol 90:922-6. 2002..76). No significant difference in outcomes between strategies was detected for a score > or =3. The TIMI risk score provides moderate incremental prognostic information in high-risk patients, during both short- and long-term follow-up...
- Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement InitiativeKaren P Alexander
Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27715, USA
J Am Coll Cardiol 46:1479-87. 2005..This study evaluated the impact of age on care and outcomes for non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
- Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trialPaul G Barnett
VA Palo Alto Health Care System, Palo Alto, Calif, USA
Circulation 105:680-4. 2002..The effects of these strategies on economic outcomes have not been established...
- Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trialAbhinav Goyal
University of Pennsylvania School of Medicine, Department of Medicine, Philadelphia, Pennsylvania 19104, USA
J Am Coll Cardiol 39:1601-7. 2002....
- The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart ADeborah B Diercks
Department of Emergency Medicine, University of California, Davis, School of Medicine, Sacramento, CA, USA
Am Heart J 152:140-8. 2006..Although obesity is a known risk factor for coronary artery disease, its impact on the presentation, treatment, and outcome of patients with acute coronary syndromes (ACS) has not been well studied...
- Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary interventionAlan H B Wu
Department of Pathology and Laboratory Medicine, Hartford, Connecticut 06102, USA
Am J Cardiol 89:1300-2. 2002
- Postpartum dissection of the left main coronary arteryIan S Rogers
Department of Medicine, Boston University Medical Center, and Boston University School of Medicine, Boston, Massachusetts, USA
Clin Cardiol 29:175-8. 2006..Furthermore, once suspected, it is imperative that a definitive diagnostic study, that is, coronary angiography, be completed prior to the initiation of treatment whenever possible...
- Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
J Am Coll Cardiol 49:1982-8. 2007..The purpose of this study was to determine the possible benefit of dual antiplatelet therapy in patients with prior myocardial infarction (MI), ischemic stroke, or symptomatic peripheral arterial disease (PAD)...
- An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trialThomas H Wang
Cleveland Clinic, Cleveland, OH, USA
Eur Heart J 28:2200-7. 2007..aspirin alone in the prespecified 'asymptomatic' subgroup of CHARISMA, we investigated whether dual-antiplatelet therapy may be associated with adverse cardiovascular (CV) events in a primary prevention population...
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt
Cleveland Clinic, Cleveland, USA
N Engl J Med 354:1706-17. 2006..Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events...
- Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early ImplementatioAndra L Blomkalns
Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0769, USA
J Am Coll Cardiol 45:832-7. 2005..We hypothesized that significant disparities in gender exist in the management of patients with non-ST-segment elevation (NSTE) acute coronary syndromes (ACS)...
- The corrected values for duration and frequency of angina at baseline in the clinical outcomes utilizing revascularization and aggressive drug evaluation trialWilliam E Boden
Am J Cardiol 100:1604. 2007
- Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw
Emory University School of Medicine, Atlanta, GA 30306, USA
Circulation 117:1283-91. 2008....
- A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am Heart J 150:401. 2005..We sought to characterize the risk factors and treatments of a diverse contemporary population of patients with atherothrombosis...
- Acute coronary syndromes without ST-segment elevation--what is the role of early intervention?William E Boden
N Engl J Med 353:1159-61. 2005
- Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary preventionWilliam E Boden
J Am Coll Cardiol 51:1255-7. 2008
- Visual assessment of left ventricular perfusion and function with electrocardiography-gated SPECT has high intraobserver and interobserver reproducibility among experienced nuclear cardiologists and cardiology traineesPeter G Danias
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
J Nucl Cardiol 9:263-70. 2002..We evaluated both intraobserver and interobserver agreement of interpretation of ECG-gated SPECT images among 3 cardiology trainees and 3 experienced nuclear cardiologists from 3 institutions...
- Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgeryJames S Kalus
Department of Drug Information, Hartford Hospital, Connecticut 06102, USA
Am J Cardiol 94:1423-5. 2004..We also found that net fluid balance on postoperative day 2 was an independent predictor of postoperative AF among patients not receiving prophylactic therapy...
- Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defectsIsaac E Silverman
Stroke Center, Hartford Hospital, University of Connecticut School of Medicine, CT, USA
Conn Med 67:135-44. 2003..We describe our initial experience at Hartford Hospital with a transcatheter PFO closure system and our multidisciplinary approach...
- Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathyPeter G Danias
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
Am J Cardiol 94:14-9. 2004..Therefore, ECG-gated SPECT is very sensitive for detection of ischemic cardiomyopathy and CAD among patients with moderate to severe systolic dysfunction...
- Is there a gender paradox in the early invasive strategy for non ST-segment elevation acute coronary syndromes?Rachid A Elkoustaf
Eur Heart J 25:1559-61. 2004
- Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromesKaren P Alexander
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 155:1047-53. 2008..To describe the association between transfusion and outcomes as a function of nadir hematocrit (HCT) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
- Letter by Mamkin et al regarding article, "weekend onset of acute myocardial infarction does not have a negative impact on outcome in Japan"Igor Mamkin
Circ J 72:864; author reply 865. 2008
- Revascularization for unprotected left main stem coronary artery stenosis stenting or surgeryDavid P Taggart
Department of Cardiac Surgery, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
J Am Coll Cardiol 51:885-92. 2008..We conclude that CABG should indeed remain the preferred revascularization treatment in good surgical candidates with unprotected LMS stenosis...
- Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub
Atlanta VA Medical Center, Decatur, GA, USA
Am Heart J 151:1180-5. 2006..A multilevel regression model will assess cost-effectiveness from a net benefit perspective. These approaches should provide the most detailed assessment available of the cost-effectiveness of PCI for coronary artery disease...
- The synergistic effect of heart disease and diabetes on self-management, symptoms, and health statusChristi Deaton
The University of Manchester, Manchester, United Kingdom
Heart Lung 35:315-23. 2006..Coronary heart disease (CHD) and diabetes may have synergistic effects on symptoms, self-management, and general and cardiac-specific health status...
- Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424Leslee J Shaw
Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif 90048, USA
J Nucl Cardiol 13:685-98. 2006....